TREATMENT OF PATIENTS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) WITH A SEQUENTIAL TREATMENT CONSISTING OF ANTI-CD 20 ANTIBODY RITUXIMAB AND CHOP+GCSF CHEMOTHERAPY. (PTLD I) Votum-Nr: 2046 -Die Studie wurde geschlossen
Leitung
Prof. Dr. Stein